Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Mesothelioma of the tunica vaginalis testis is rare, often high-grade, and has a median survival of about 24 months.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

The woman has a skin condition involving nodules, scars, and hair loss.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.